Dr. Marcus S. Albernaz, MD

Dr. Albernaz practices at Eastern Carolina Ear, Nose & Throat-Head & Neck Surgery, Inc in Greenville, North Carolina.

Dr. Albernaz's NPI, 1942254859, was assigned on May 22, 2006. Dr. Albernaz graduated from Northeast Ohio Medical University in 1984. Dr. Albernaz holds North Carolina license 37784.

Dr. Albernaz's primary practice is Eastern Carolina Ear, Nose & Throat-Head & Neck Surgery, Inc, at 850 Johns Hopkins Dr, Greenville, NC 27834 in Pitt County. The practice phone is (252) 752-5227.

Dr. Albernaz's primary practice is Eastern Carolina Ear, Nose & Throat-Head & Neck Surgery, Inc in Greenville, North Carolina. Dr. Albernaz is also affiliated with ECU Health Medical Center. The medical group on file is NovaCare Rehabilitation. Dmand AI also links Dr. Albernaz to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Albernaz practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Albernaz's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Albernaz is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Albernaz's licenses on file in 2 states: North Carolina and South Carolina.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery and hearing loss and impairment among the conditions Dr. Albernaz treats.

CMS data shows 1,255 Medicare services from Dr. Albernaz across 13 procedure codes in 2024, for 395 Medicare patients. Medicare paid $73,147 for them.

CMS counts 395 Medicare patients who saw Dr. Albernaz in 2024. The largest group is 65 to 74, with 165 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Albernaz's median patient age at 43, with 55% women.

In 2024, Dr. Albernaz wrote 1,081 Medicare Part D claims for 373 patients. 95% of them were for generic drugs. CMS names the drug for 939 of them, across 15 drugs with 11 or more claims each, at $64,972 in total drug cost. In 2023, CMS named 1,023 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 71 out of 100 for Dr. Albernaz for performance year 2024, reported individually. Dr. Albernaz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Albernaz as offering telehealth.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Albernaz. Dr. Albernaz's most frequent co-author is Mark Thomas Emery, MD.

CMS Open Payments shows 32 general payments to Dr. Albernaz from 13 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $363.

Dmand AI lists 2 awards for Dr. Albernaz.

Dr. Albernaz graduated from Northeast Ohio Medical University in 1984. Dr. Albernaz is a member of NHS and ACS.

Dr. Albernaz is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.